Eli Lilly has shown patients maintained most of their weight loss after switching from injectable GLP-1s to its oral drug candidate, teeing the drugmaker up to target people taking Novo Nordisk’s ...

Jess Loren remembers loving the taste of Cap'n Crunch cereal. Coca-Cola. Snickers bars. But now, instead of a sweetness, "they taste bland," she says. Flavors are noticeably muted since she started a ...

GLP-1 usage is on the rise, and researchers are looking for other health benefits associated with the drug, including its effects on bladder health. But as GLP-1s rise in popularity, so do nicknames ...

SALT LAKE CITY — Weight-loss drugs have surged in popularity in recent years, with as many as 12% of Americans having tried a glucagon-like peptide-1 (GLP-1) medication such as Ozempic, Wegovy, ...

Now, GLP-1s are available for weight loss, but plenty of misconceptions exist about how best to use these drugs. It may sound nice to think about taking GLP-1s and watching the numbers on your scale ...

The World Health Organization conditionally recommends the use of GLP-1 drugs, including tirzepatide, marketed as Mounjaro and Zepbound, for obesity treatment. Peter Dazeley via Getty Images The World ...

XREAL is wrapping up 2025 with the launch of a new entry-level AR glasses model, the XREAL 1S. It sits below the more expensive XREAL One Pro (announced in July) in the lineup and is the first in the ...

Dr. Jennah Siwak breaks down the factors she and her patients weigh when deciding if GLP-1 medications are the right fit. Glucagon-like peptide-1 (GLP-1) medications, which mimic a natural gut hormone ...

CHICAGO, Nov 25 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of blockbuster drugs Ozempic and ...

Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics. More companies are promoting microdosing ...

Medicare will begin covering weight loss drugs in 2026 for the first time under a pricing agreement announced by the White House, according to a Nov. 6 press release. The agreements with Eli Lilly and ...